Eu­ro­pean Com­mis­sion opens in­ves­ti­ga­tion in­to Vi­for for po­ten­tial­ly dis­parag­ing a com­peti­tor

As the Eu­ro­pean Com­mis­sion looks to strength­en the phar­ma sec­tor’s com­pet­i­tive­ness, the com­mis­sion is al­so crack­ing down on the sec­tor in new ways.

The com­mis­sion on Mon­day opened a for­mal an­titrust in­ves­ti­ga­tion in­to Swiss-based Vi­for Phar­ma to see if the com­pa­ny has re­strict­ed com­pe­ti­tion by il­le­gal­ly dis­parag­ing its clos­est and po­ten­tial­ly its on­ly com­peti­tor in Eu­rope, the Dan­ish phar­ma com­pa­ny Phar­ma­cos­mos and its drug to com­bat iron de­fi­cien­cy Monofer.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER